Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...
Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Many HIV-serodiscordant couples desire children and physician-assisted techniques can help individuals achieve pregnancy while reducing the risk of seroconversion in their seronegative partner. For ...
Campaigners in Northern Ireland have called for the introduction of a 'game-changing' drug that will prevent HIV. On Friday it was announced cabotegravir (CAB-LA) injections will be introduced in ...
Nicotine & Tobacco Research, Vol. 18, No. 12 (December 2016), pp. 2185-2193 (9 pages) Introduction: HIV-positive people are often more susceptible to illnesses associated with smoking, for example, ...
Background. Invasive pneumococcal disease (IPD) is an important cause of morbidity among individuals infected with human immunodeficiency virus (HIV). We described incidence and risk factors for IPD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback